Chem. J. Chinese Universities ›› 2012, Vol. 33 ›› Issue (08): 1850.doi: 10.3969/j.issn.0251-0790.2012.08.038

• Polymer Chemistry • Previous Articles     Next Articles

Synthesis and Properties of Ethylene-polyhedral Oligomeric Silsesquioxane Copolymer with Bis(cyclopentadienyl) Zirconium Dichloride Catalyst

ZHANG He-Xin1, ZHANG Hao1,3, ZHANG Chun-Yu1, HAO Xiu-Feng1,2, ZHANG Xue-Quan1   

  1. 1. High Performance Synthetic Rubber Engineering Research Center, Changchun Institute of Applied Chemistry, Chinese Academy of Science, Changchun 130022, China;
    2. College of Chemistry, Jilin University, Changchun 130012, China;
    3. College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China
  • Received:2011-10-10 Online:2012-08-10 Published:2012-08-10

Abstract: An organic/inorganic hybrid copolymer was prepared with a bis (cyclopentadienyl) zirconium dichloride (Cp2ZrCl2) in conjunction with modified methylaluminoxane (MMAO) cocatalyst. Two kinds of monovinyl substituted polyhedral oligomeric silsesquioxane(POSS) monomers were used to copolymerize with ethylene(E). The copolymers were characterized with 1H NMR, DSC, TGA and GPC to know the composition, thermal properties, molecular weight and its distribution, respectively. The comonomer content (POSS) was in the range of 0.01%-0.30%(molar fraction). With the increase of POSS content in copolymer, the melting temperature and heat of fusion decreased. Thermogravimetric analysis of E/POSS copolymers exhibited an improved thermal stability with a higher degradation temperature and char yields, demonstrating that the inclusion of inorganic POSS nanoparticles made the organic polymer matrix more thermal robust. Increasing the feed ratio of POSS, the molecular weight increased, while the molecular weight distribution broadened.

Key words: Hybrid copolymer, Copolymerization, Nanocomposite, Ethylene, Polyhedral oligomeric silsesquioxane(POSS), bis(cyclopentadienyl) zirconium dichloride(Cp2ZrCl2) catalyst

CLC Number: 

TrendMD: